Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
PUMA BIOTECHNOLOGY, INC. (PBYI)
Sector: Healthcare; Industry: Biotechnology

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care. The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-06-16 Senderowicz Adrian Director Sell 27,858 $2.63 $73,303 No
2022-06-16 WILSON TROY EDWARD Director Sell 27,858 $2.58 $71,971 No
2022-06-16 Stuglik Brian M Director Sell 13,000 $2.69 $34,918 No
2022-06-16 MOYES JAY M Director Sell 22,858 $2.64 $60,370 No
2022-06-02 Wong Alvin F Chief Scientific Officer Sell 587 $1.92 $1,129 No
2022-06-02 NOUGUES MAXIMO F Chief Financial Officer Sell 162 $1.92 $311 No
2022-06-02 HUNT DOUGLAS M nan Sell 417 $1.94 $811 No
2022-06-02 AUERBACH ALAN H President and CEO Sell 1,200 $1.94 $2,333 No
2022-05-03 HUNT DOUGLAS M nan Sell 438 $2.31 $1,012 No
2022-05-03 NOUGUES MAXIMO F Chief Financial Officer Sell 165 $2.34 $386 No
2022-05-03 NOUGUES MAXIMO F Chief Financial Officer Sell 165 $2.34 $386 No
2022-05-03 NOUGUES MAXIMO F Chief Financial Officer Sell 165 $2.34 $386 No
2022-05-03 AUERBACH ALAN H President and CEO Sell 1,263 $2.32 $2,930 No
2022-04-04 AUERBACH ALAN H President and CEO Sell 1,198 $3.08 $3,687 No
2022-04-04 HUNT DOUGLAS M nan Sell 413 $3.08 $1,271 No
2022-04-04 NOUGUES MAXIMO F Chief Financial Officer Sell 206 $3.08 $634 No
2022-03-16 MILLER MICHAEL PATRICK Director Sell 25,653 $2.80 $71,792 No
2022-03-02 NOUGUES MAXIMO F Chief Financial Officer Sell 169 $2.26 $382 No
2022-03-02 AUERBACH ALAN H President and CEO Sell 1,294 $2.26 $2,919 No
2022-02-02 HUNT DOUGLAS M nan Sell 533 $2.47 $1,317 No
2022-02-02 AUERBACH ALAN H President and CEO Sell 1,316 $2.46 $3,239 No
2022-01-03 Ludwig Jeffrey Jerome Chief Commercial Officer Sell 4,727 $3.20 $15,121 No
2022-01-03 HUNT DOUGLAS M nan Sell 3,707 $3.21 $11,890 No
2022-01-03 NOUGUES MAXIMO F Chief Financial Officer Sell 7,484 $3.19 $23,871 No
2021-12-02 HUNT DOUGLAS M nan Sell 441 $2.90 $1,279 No
2021-12-02 NOUGUES MAXIMO F Chief Financial Officer Sell 162 $2.95 $478 No
2021-12-02 AUERBACH ALAN H President and CEO Sell 1,837 $2.90 $5,327 No
2021-11-02 NOUGUES MAXIMO F Chief Financial Officer Sell 156 $5.67 $885 No
2021-11-02 HUNT DOUGLAS M nan Sell 427 $5.64 $2,409 No
2021-10-04 NOUGUES MAXIMO F Chief Financial Officer Sell 161 $6.20 $998 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.